Tang X, Wu H, Mao X, Li X, Wang Y (2020) The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and -endorphin
Long-term (ongoing after first 6 months) Sometimes called the maintenance phase, by now all potential gastro-intestinal side effects have usually disappeared. Appetite has started to increase, but not to the level prior to starting the medication. Weight loss has started to decrease or even stopped and remained stable
Millions of people now understand that these hormones are central to weight regulation, thanks to the media coverage around drugs like semaglutide and tirzepatide
It is the single most important factor in tolerating semaglutide without debilitating side effects
Meneguello, MA
They also reported improved knee function, with a 12-point gain in mobility scores versus a 6.5-point increase in the placebo group